|
FIGNL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.349600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.500800E-01 |
| Normal-vs-Stage2 |
6.765900E-02 |
| Normal-vs-Stage3 |
5.045400E-01 |
| Normal-vs-Stage4 |
6.420000E-01 |
| Stage1-vs-Stage2 |
7.306000E-02 |
| Stage1-vs-Stage3 |
2.573800E-01 |
| Stage1-vs-Stage4 |
4.375800E-01 |
| Stage2-vs-Stage3 |
2.364100E-02 |
| Stage2-vs-Stage4 |
5.113500E-02 |
| Stage3-vs-Stage4 |
9.369000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.558800E-01 |
| Normal-vs-AfricanAmerican |
5.429200E-01 |
| Normal-vs-Asian |
4.219000E-01 |
| Caucasian-vs-AfricanAmerican |
3.706600E-01 |
| Caucasian-vs-Asian |
5.588000E-01 |
| AfricanAmerican-vs-Asian |
2.652400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.422770E-01 |
| Normal-vs-Female |
7.291800E-01 |
| Male-vs-Female |
1.401740E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.100200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.709800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.021800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.444800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.487400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.287200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.631000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.759000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.665600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.706400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.621900E-02 |
| Classical-VS-Follicular |
1.62436730732907E-12 |
| Classical-VS-Other |
7.279600E-02 |
| Classical-VS-Normal |
1.214580E-01 |
| Tall-VS-Follicular |
3.3386999831464E-09 |
| Tall-VS-Other |
1.006460E-02 |
| Tall-VS-Normal |
3.515200E-03 |
| Follicular-VS-Other |
2.511800E-01 |
| Follicular-VS-Normal |
6.18539996999345E-09 |
| Other-VS-Normal |
1.277640E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.323960E-01 |
| Normal-vs-N1 |
7.571800E-01 |
| N0-vs-N1 |
1.269360E-01 |
|
|
